









Markets
/
Stocks
/
nasdaq-abvx
/

Abivax SA

ABVX

View Detailed Chart

71.945USD

+0.175+0.24%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

0.00Market Cap

--P/E TTM



Abivax SA

71.945

+0.175+0.24%

Overview Company Financials

Financials

Intraday

30m

Today

+0.24%

5 Days

+8.20%

1 Month

+803.83%

6 Months

+1111.20%

Year to Date

+882.86%

1 Year

+501.04%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 7 analysts

BUY

Current Rating

86.571

Target Price

20.33%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

Abivax SA

ABVX

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Ionis Pharmaceuticals Inc

IONS

Exact Sciences Corp

EXAS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Buy

Sell(1)

Neutral(1)

Buy(8)

Indicators

Sell(1)

Neutral(1)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

9.828

Buy

RSI(14)

93.644

Overbought

STOCH(KDJ)(9,3,3)

94.533

Overbought

ATR(14)

6.768

High Vlolatility

CCI(14)

62.949

Neutral

Williams %R

5.348

Overbought

TRIX(12,20)

14.683

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

70.184

Buy

MA10

57.591

Buy

MA20

33.217

Buy

MA50

17.422

Buy

MA100

11.917

Buy

MA200

9.996

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Abivax SA is a clinical stage biopharmaceutical company focusing on the discovery, development and commercialization of anti-viral compounds and therapeutic vaccines against severe and life threatening infectious diseases. ABIVAX utilizes RNA-protein interaction interference and cytotoxic TH1 cell amplification to generate therapies to help patients clear viruses like HIV, HBV and HPV. The Company's product pipeline comprises ABX 203, which is the therapeutic vaccine candidate obtained from the Centre for Genetic Engineering and Biotechnology, Cuba (CIGB) and is intended for patients with chronic hepatitis B disease; and ABX196, the adjuvant for therapeutic vaccines, among others.

Ticker SymbolABVX

CompanyAbivax SA

CEOMr. Marc De Garidel

Websitehttps://www.abivax.com/